Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Pancreatic Neoplasms and MDM2[original query] |
---|
MDM2 promoter polymorphism and pancreatic cancer risk and prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jun 14 (12): 4010-5. Asomaning Kofi, Reid Amy E, Zhou Wei, Heist Rebecca S, Zhai Rihong, Su Li, Kwak Eunice L, Blaszkowsky Lawrence, Zhu Andrew X, Ryan David P, Christiani David C, Liu Geoffr |
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Annals of surgical oncology 2009 Feb 16 (2): 431-9. Chen Jinyun, Li Donghui, Killary Ann M, Sen Subrata, Amos Christopher I, Evans Douglas B, Abbruzzese James L, Frazier Marsha |
MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 3431-8. Chen Bo, Cao Lei, Hu Kong-Wang, Zhang Jia-Wei, Meng Xiang-Ling, Xiong Mao-Mi |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: